ZIRCON: Pharmacokinetics, safety, and efficacy of ombitasvir/ paritaprevir/ritonavir ± dasabuvir ± ribavirin in adolescents with genotype 1 or 4 hepatitis C virus infection

Authors
Category Primary study
JournalJournal of Hepatology
Year 2017
This article has no abstract
Epistemonikos ID: 9ba2b87dcc5917b257d0bb7d4e0e59c7058d8bf0
First added on: Feb 09, 2025